← Back to Search

Time Restricted Eating for Weight Management

N/A
Waitlist Available
Led By Krista Varady, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 to 70 years old
BMI between 30 and 50 kg/m2
Must not have
Perimenopausal or have an irregular menstrual cycle (menses that does not appear every 27-32 days)
Type 1 DM or Type 2 DM
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at month 0, 6 and 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if time-restricted eating can help people with obesity and prediabetes manage their weight and improve their insulin sensitivity.

Who is the study for?
This trial is for adults aged 18-70 with obesity (BMI of 30-50) who are sedentary or lightly active. It's not suitable for those unstable in weight, on certain medications, unable to maintain a food/activity log, with eating disorders, irregular menstrual cycles, smokers, diabetics, night shift workers, or pregnant individuals.
What is being tested?
The study tests if eating within an 8-hour window (12pm-8pm) leads to better weight management compared to daily calorie restriction or no intervention over a year. Participants will first focus on losing weight for six months and then maintaining it for another six.
What are the potential side effects?
Potential side effects may include hunger during fasting periods, possible changes in energy levels and mood swings due to altered meal timing and reduced calorie intake.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.
Select...
My BMI is between 30 and 50.
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My menstrual cycle is irregular or I am perimenopausal.
Select...
I have diabetes (Type 1 or Type 2).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at month 0, 6 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at month 0, 6 and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in body weight
Secondary study objectives
Adverse events
Change in Blood pressure
Change in Fasting glucose
+26 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Calorie restrictionExperimental Treatment1 Intervention
25% energy restriction every day
Group II: 8-hour Time restricted eatingExperimental Treatment1 Intervention
Ad libitum food intake from 12-8 pm every day Fasting from 8-12 pm every day (16-h fast)
Group III: ControlActive Control1 Intervention
Usual diet, Ad libitum intake, eating within \>10 hours per day

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
640 Previous Clinical Trials
1,568,618 Total Patients Enrolled
36 Trials studying Obesity
10,189 Patients Enrolled for Obesity
Krista Varady, PhDPrincipal InvestigatorUniversity of Illinois Chicago
5 Previous Clinical Trials
571 Total Patients Enrolled
4 Trials studying Obesity
540 Patients Enrolled for Obesity

Media Library

8-hour Time restricted eating Clinical Trial Eligibility Overview. Trial Name: NCT04692532 — N/A
Obesity Research Study Groups: Control, 8-hour Time restricted eating, Calorie restriction
Obesity Clinical Trial 2023: 8-hour Time restricted eating Highlights & Side Effects. Trial Name: NCT04692532 — N/A
8-hour Time restricted eating 2023 Treatment Timeline for Medical Study. Trial Name: NCT04692532 — N/A
~25 spots leftby Jul 2026